baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Summit Therapeutics Inc/ US86627T1088 /

5/15/2024 10:00:00 PM	Chg. -0.1950	Volume	Bid10:06:22 PM	Ask10:06:22 PM	High	Low
4.4900USD	-4.16%	1.84 mill. Turnover: 7.12 mill.	4.4300Bid Size: 300	4.5700Ask Size: 100	4.8899	4.4100

GlobeNewswire 5/10 ProKidney Reports Business Updates and First Quarter 2024 Financial Results

GlobeNewswire 3/25 ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

GlobeNewswire 3/7 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...

GlobeNewswire 2/28 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...

GlobeNewswire 2/21 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...

GlobeNewswire 2/8 Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors

GlobeNewswire 3/17/2022 Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter an...

GlobeNewswire 2/9/2022 Summit Therapeutics Announces Postponement of Its Planned Rights Offering

GlobeNewswire 2/1/2022 Dr. Maky Zanganeh Launches Personal Memoir, the Magic of Normal, to Honor February Cancer Survivor M...

GlobeNewswire 1/25/2022 Summit Therapeutics Announces Rights Offering

GlobeNewswire 1/10/2022 Summit Therapeutics Today Presents Its Company Vision at 40th Annual J.P. Morgan Healthcare Virtual ...

GlobeNewswire 1/5/2022 Summit Therapeutics to Present Company Vision at 40th Annual J.P. Morgan Healthcare Virtual Conferen...

GlobeNewswire 12/20/2021 Summit Therapeutics Announces Topline Results for Phase III Ri-CoDIFy Study for C. Difficile Infecti...

GlobeNewswire 11/15/2021 Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and...

GlobeNewswire 11/4/2021 Entasis Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update

GlobeNewswire 11/3/2021 Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Exe...

GlobeNewswire 10/11/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...

GlobeNewswire 10/8/2021 Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of...

GlobeNewswire 10/4/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...

GlobeNewswire 9/30/2021 Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action...

GlobeNewswire 9/24/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...

GlobeNewswire 8/11/2021 Entasis Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

GlobeNewswire 8/11/2021 Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Si...

GlobeNewswire 8/11/2021 Summit Therapeutics Provides Update on Ri-CoDIFy Trials

GlobeNewswire 7/14/2021 Entasis Therapeutics Expands Executive Leadership Team with the Appointment of Anna Diaz Triola as C...

Summit Therapeutics Inc/ US86627T1088 /

If you wish to receive reply to your feedback, please provide your email address.